Clinical Trials
4 trialsNCT05983159 2026-05-05
TARGET-VM
Murdoch Childrens Research Institute
Phase 2 Recruiting
NCT07477548 2026-03-17
A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies
Yonsei University
Phase 2 Not yet recruiting
NCT02110069 2023-09-21
A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Boston Children's Hospital
Phase 2 Terminated
NCT01408056 2014-01-17
TOUCH
Children's Hospital of Philadelphia
Phase 2 Withdrawn